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Abstract
Empyema thoracis is a complex pleural infection disease that can evolve 
into three pathological phases: exudative, fibrinopurulent, and organized. 
Each stage presents with its own characteristics and relevant treatment 
strategies. Organized empyema, defined as pleural fibrosis with peel for-
mation, often requires thoracotomy and decortication to expand the 
entrapped lung. In chronically ill, debilitated, or elderly patients superim-
posed with organized empyema, more invasive operative approaches are 
likely to result in higher procedure-related morbidities and mortalities. 
On the other hand, less invasive procedures would also be inappropriate 
because of frequently ineffective drainage or consistent lung encasement 
(e.g. prolonged catheter insertion, intrapleural fibrinolysis, or thoraco-
scopic debridement). Here, we report two elderly patients with concomi-
tant illnesses who developed organized empyema and had no response 
to nonoperative management. Both patients recovered completely after 
video-assisted thoracoscopic surgery debridement, proper chest tube 
placement, and urokinase instillation to resolve residual thick peels. Less 
invasive surgical treatment combined with the use of fibrinolytic agents 
may be an option in treating patients with organized empyema who cannot 
tolerate decortication. [Tzu Chi Med J 2009;21(3):255–260]
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1. Introduction
Empyema thoracis remains a frequently encountered 
clinical problem. If adequate drainage of the pleural 
space in the exudative, fibrinopurulent or organized 
phases is not prompt and effective, the patient will 
often experience prolonged hospitalization, develop-
ment of systemic toxicity, increased morbidity from 
drainage procedures, increased risk of residual ven-
tilatory impairment, and increased mortality [1]. The 
optimal treatment of pleural empyema has been 
widely debated, and therapeutic approaches differ 
between physicians ranging from thoracentesis, tube 
thoracostomy drainage, drainage plus intrapleural 
instillation of fibrinolytic agents, video-assisted thora-
coscopic surgery (VATS), and surgery with or without 
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decortication and rib resection [1]. In general, if 
drainage is incomplete due to the infection location, 
intrapleural fibrinolytic drugs should be supplied, or 
thoracoscopic debridement conducted. If the lung 
does not re-expand completely because of pleural 
peel formation, decortication should be carried out 
without delay [2]. Up to 40% of empyema patients 
come to surgery because of failed catheter drainage 
and, overall, 20% of patients with empyema die. Rapid 
evaluation of its status and proper therapeutic inter-
vention appear to reduce morbidity and mortality, as 
well as healthcare costs [3]. The key to successful 
treatment lies in effective pleural evacuation and re-
expansion of the lung. In the late organized stage of 
empyema thoracis—accompanied by thick peel forma-
tion and an entrapped lung—open decortication is 
considered the most appropriate treatment in terms 
of efficacy and length of hospital stay [4]. Here, we 
present two patients in which organized empyema tho-
racis was successfully managed with VATS debride-
ment followed by the use of intrapleural fibrinolysis.
2. Case reports
2.1. Case 1
A 72-year-old man presented with fever, productive 
cough, and shortness of breath for about 1 week. He 
had a history of gastroesophageal reflux disease and 
chronic hepatitis C without regular treatment. Years 
before presentation, he received craniotomy (for right 
cerebellar hemangioblastoma) and a ventriculoperi-
toneal shunt (for hydrocephalus formation). Acute 
respiratory failure occurred after the operation and 
tracheostomy was then performed. During hospitali-
zation, he developed rhonchi of the left lung and co-
pious thick yellowish sputum from the tracheostomy 
tube. Chest radiography showed a pneumonic patch 
in the left lower lobe (Fig. 1A) and leukocytosis 
(13,470/μL) was observed. Despite early use of broad-
spectrum antibiotics, his pneumonia rapidly pro-
gressed to a huge loculated effusion occupying 
nearly the entire left pleural cavity with midline shift-
ing on the following chest films (Fig. 1B). Pigtail cath-
eter drainage (14F inter-V; PBN Medicals A/S, Stenløse, 
Denmark) under ultrasound guidance was carried out 
to disclose turbid fluid and increased echogenicity, 
compatible with the multiloculated fluid collections 
with encapsulation detected on chest computed to-
mography (CT) scan (Fig. 1C). With no improvement 
of his symptoms and inadequate drainage by the pig-
tail catheter (Fig. 1D), VATS under general anesthesia 
was undertaken 2 weeks later, revealing thick peels 
overlying both pleurae. Bleeding occurred readily on 
contact during instrumental debridement of the de-
posited necrotic tissue and constrictive hard rinds 
via the thoracoscopic working channel—this made it 
impossible to proceed with the decortication proce-
dure. One 28-Fr chest tube (P.V.C. thoracic catheter; 
Sewoon Medical Co. Ltd, Seoul, Korea) was then 
placed through the port and another 28-Fr chest tube 
was put separately into the upper part of the encap-
sulated empyema cavity during the operation to in-
crease drainage and to make later fibrinolysis of the 
tight peels more feasible. Postoperative chest radiog-
raphy showed diffuse thick peels hampering the left 
lung and formation of a huge cavity after negative 
pressure was applied to the chest tubes (Fig. 1E). 
Therefore, we started fibrinolytic therapy, instilling 
urokinase 120 KIU (urokinase-GCBT 250 KIU/vial; 
Korea Green Cross Corp., Gyeonggi, Korea), mixed 
with 100 mL of normal saline, into the pleural cavity 
through the upper chest tube, followed by clamping 
of both tubes and postural changes of the patient for 
2 hours. The procedure was repeated on alternate 
days for a total of six treatments. There was constant 
putrid fluid drainage from the dependent tube after 
initial clamping and no hemorrhagic complications 
occurred. The upper chest tube was removed 3 weeks 
postoperatively and the patient was discharged with 
the lower tube in place for open drainage. The tube 
was gradually pulled out and the patient completely 
recovered with full expansion of the left lung 3 months 
later (Fig. 1F).
2.2. Case 2
An 81-year-old man presented with chest pain and 
cough with yellowish sticky sputum for 2 weeks. High 
fever with intercurrent chills also developed 2 days 
before admission. He had a history of hypertension 
and type II diabetes mellitus for more than 20 years 
and received medications irregularly. Leukocytosis 
(21,420/μL) was observed and initial chest radiogra-
phy showed interstitial infiltrations over the right lower 
lobe that was diagnosed as pneumonia; empirical 
antibiotics were then prescribed. A CT scan demon-
strated basal lung consolidation and partial collapse 
of the right lower lobe with a loculated parapneu-
monic pleural effusion (Fig. 2A), compatible with the 
findings of septate fluid collections on thoracic ultra-
sound (Fig. 2B). Pleural tapping and pigtail catheter 
drainage (14F inter-V; PBN Medicals A/S)—guided by 
ultrasound—were performed. The aspirated yellowish 
fluid yielded no growth on bacterial culture. However, 
the encapsulated effusion rapidly enlarged with inter-
lobar extension on chest radiography (Fig. 2C). VATS 
was then conducted under general anesthesia using 
a double-lumen endotracheal tube. The right lung 
densely adhered to the chest wall with the lower lobe 
severely encased by thick peel and necrotic tissue. 
This was found particularly at the costophrenic angle 
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and diaphragmatic region, where a foul-smelling 
putrid fluid accumulation was also found. Instru-
mental debridement of the overlying necrotic tissue 
via the thoracoscopic working channel was done as 
adequately as possible. One 32-Fr chest tube (P.V.C. 
thoracic catheter; Sewoon Medical Co. Ltd.) was in-
serted via the port with part of the encompassed hard 
peels remaining. The fever subsided after the opera-
tion and the patient received intrapleural urokinase 
treatment (urokinase-GCBT 250 KIU/vial; Korea 
Green Cross Corp.) once per day for 3 consecutive 
days. Each treatment consisted of urokinase 120 KIU 
in 100 mL of normal saline administered via the chest 
tube, followed by clamping of the tube for 2 hours. 
The patient’s total hospital stay was 3 weeks. The 
chest tube was removed prior to discharge with com-
plete expansion of the right lung (Fig. 2D).
3. Discussion
We reported two elderly, debilitated patients who 
developed pleural infections that evolved into the 
organized phase of empyema thoracis. Both patients 
had complete recoveries after VATS with one-port 
thoracoscopic debridement, followed by intrapleural 
urokinase fibrinolytic therapy.
Empyema thoracis is a common disease entity 
and frequently develops in chronically ill, debilitated, 
or immunocompromised patients with various un-
derlying comorbidities. It can progress very rapidly 
as in our patients, and, if diagnosis or treatment is 
delayed, may be associated with prolonged hospital 
stay and increased morbidity and mortality [2]. The 
therapeutic options including antibiotics, thoracen-
tesis, chest intubation, fibrinolytic therapy, VATS, 
and open thoracotomy may vary depending on the 
stage of the disease [5]. VATS debridement is consid-
ered a primary treatment strategy in the fibrin puru-
lent phase of the illness with respect to treatment 
efficacy, hospital duration, duration of chest tube 
placement, and the need for subsequent procedures 
[6,7]. Early decortication by VATS or thoracotomy is 
suggested for both adults and children who develop 
organized empyema thoracis associated with forma-
tion of a thick fibrinous peel. It achieves proper lung 
Fig. 1 — (A) Chest radiography at presentation shows a pneumonic patch over the left lower lobe and a tracheostomy 
tube in place. (B) A huge encapsulated pleural effusion occupying nearly the entire left pleural cavity, with the midline 
shift seen on subsequent chest radiography. (C) Chest computed tomography scan demonstrates encapsulated fluid 
collection and partial collapse of the left lung. (D) Chest radiography shows inadequate drainage following pigtail 
catheter insertion. (E) Diffuse thick peel hampering the left lung and huge cavity formation after chest tube drainage. 
(F) Chest radiography 3 months after surgery shows re-expansion of the left lung.
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re-expansion, and decreases hospital stay and total 
health costs [5,8]. For chronic or complicated em-
pyema, partial rib resection and chest wall muscle 
flap application [9] has been proposed as a safe and 
definitive surgical procedure, although it often results 
in higher morbidity and prolonged recovery time.
Since the 1990s, fibrinolysis and early VATS have 
emerged as two new treatment modalities for thoracic 
empyema. Many institutions are now using one of 
these methods as first-line therapy because they result 
in shorter hospital stay and fewer complications than 
the conservative approach [10]. Moreover, nearly half 
of patients with sonographically stratified multilocu-
lated empyema need intrapleural fibrinolysis after 
thoracoscopic debridement to achieve satisfactory 
results [11]. In the organized stage of empyema tho-
racis—complicated by multiloculated pleural effusion 
or pus collection—as in both of our patients, open 
decortication is the most appropriate method to clear 
the thick constrictive rind overlying the pleurae [4]. 
However, we attempted thoracoscopic debridement 
instead of the more invasive procedure to minimize 
postoperative events in these elderly, debilitated pa-
tients. In fact, bleeding occurred even during thora-
coscopic manipulation in our first patient. The use of 
VATS debridement alone was obviously inadequate 
for clearing the peels and re-expanding the lung; 
conversion to open decortication was also not feasi-
ble, so we decided to treat the residual thick peel 
later with fibrinolytic therapy.
Pigtail tube drainage—guided by chest ultrasound—
is often used as an initial step for the management of 
infected intrapleural fluid collections, but it often fails 
due to tube kinking, malposition, or blockage [12]. 
Fig. 2 — (A) Computed tomography demonstrates consolidation of the right lower lobe with multiloculated parapneu-
monic pleural effusion. (B) Ultrasound findings of septate fluid collections. Chest radiography shows: (C) enlarging 
loculated effusion with interlobar extension after pigtail catheter drainage; (D) full expansion of the right lung after 
chest tube removal.
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This leads to clinical and radiographic deterioration, 
as exemplified in the patients described in this study. 
One-port thoracoscopy—with instrument insertion 
through the working channel of the scope and video 
monitoring assistance—is an alternative for thorough 
deloculation and debridement. It is particularly use-
ful for deposited necrotic tissue and fibrinous peel 
coating. The small port wound can also be used for 
chest tube insertion. We believe this approach is less 
invasive and better tolerated, with good therapeutic 
results and minimal postoperative complications. It 
is at least as effective as VATS, which involves more 
ports. In cases where thoracoscopy discloses exten-
sive thick peel formation hampering most of the dis-
eased lung, which limits the procedure to incomplete 
debridement of the space, we may still be able to 
administer intrapleural urokinase postoperatively to 
expand the underlying entrapped lung.
Intrapleural fibrinolytic therapy using agents such 
as streptokinase, urokinase, or tissue plasminogen 
activator may lyse the fibrinous strands and thereby 
clear the lymphatic pores—this is recommended for 
any complicated parapneumonic effusion or em-
pyema [13,14]. Cumulative evidence suggests that 
these agents are more effective and safer in children 
than in adults, although intrapleural administration 
of streptokinase does not improve mortality, the rate 
of surgery, or the length of the hospital stay of patients 
with pleural infection [15,16]. It was reported that 
about 21–31% of patients with empyema thoracis 
who underwent fibrinolytic therapy failed to respond 
clinically or radiographically and only recovered after 
open thoracotomy, although no major complications 
or mortality occurred during fibrinolysis [17,18]. In 
both of our patients, however, the remaining intra-
pleural peels were completely resolved eventually with-
out any sequelae after using urokinase instilled through 
the chest tube. We think this treatment modality is a 
safe and effective way to increase pleural circulation 
and chest tube drainage without causing systemic 
fibrinolysis. It is indicated if there is unsatisfactory 
radiographic improvement even with constant drain-
age or after inadequate VATS debridement of em-
pyema thoracis. In our second patient, it may have 
contributed to full lung expansion when combined 
with thoracoscopic management.
Although an indwelling pleural catheter has been 
suggested to treat chronic pleural infection [19], we 
prefer to use a large-bore chest tube both for ade-
quate drainage when connected (if necessary) to a 
negative-pressure suction device, and for later fibri-
nolytic therapy in this specific stage of empyema tho-
racis. We believe it can also shorten the protracted 
clinical course and achieve the goal of complete ex-
pansion of the entrapped lung, which is particularly 
important in these patients. Our first patient was 
even discharged with open chest tube drainage for the 
residual pus, and the tube was eventually removed 
uneventfully. Our method provides another option in 
treating patients with organized empyema thoracis 
who are considered poor surgical candidates. It re-
sults in only a small thoracostomy wound and causes 
less postoperative pain and procedure-related mor-
bidity than open decortication. In addition, intrap-
leural urokinase fibrinolytic therapy appears to be an 
optimal strategy to preserve lung function and spare 
patients the morbidity and mortality risk of a thora-
cotomy. Further study with more patients is needed 
to determine whether it results in early recovery, less 
antibiotic coverage, and a better quality of life in 
these patients.
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